FBRX – Forte Biosciences Inc
Forte Biosciences, Inc.FBRX
$6.80Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $44,766,984.00
EPSttm : -12.17
Forte Biosciences, Inc.
$6.80
7.26%$0.46Float Short %
2.06
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
8.57
EPS This/Next Y
1.35
Price
6.8
Target Price
59
Analyst Recom
1
Performance Q
-38.79
Relative Volume
0.19
Beta
2.77
Ticker: FBRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | FBRX | 5.58 | N/A | N/A | 0 |
| 2025-04-15 | FBRX | 5.84 | N/A | N/A | 0 |
| 2025-04-16 | FBRX | 7.3 | N/A | N/A | 0 |
| 2025-04-17 | FBRX | 6.81 | N/A | N/A | 0 |
| 2025-04-18 | FBRX | 7.34 | N/A | N/A | 0 |
| 2025-04-21 | FBRX | 7.08 | N/A | N/A | 0 |
| 2025-04-22 | FBRX | 6.76 | N/A | N/A | 0 |
| 2025-04-23 | FBRX | 6.03 | N/A | N/A | 0 |
| 2025-04-24 | FBRX | 6.96 | N/A | N/A | 0 |
| 2025-04-25 | FBRX | 6.24 | N/A | N/A | N/A |
| 2025-04-28 | FBRX | 7.12 | N/A | N/A | N/A |
| 2025-04-29 | FBRX | 7.34 | N/A | N/A | 0 |
| 2025-04-30 | FBRX | 7.26 | N/A | N/A | 0 |
| 2025-05-01 | FBRX | 7.16 | N/A | N/A | 0 |
| 2025-05-02 | FBRX | 6.96 | N/A | N/A | 0 |
| 2025-05-05 | FBRX | 6.65 | N/A | N/A | 0 |
| 2025-05-06 | FBRX | 6.32 | N/A | N/A | 0 |
| 2025-05-07 | FBRX | 6.16 | N/A | N/A | 0 |
| 2025-05-08 | FBRX | 6.45 | N/A | N/A | 0 |
| 2025-05-09 | FBRX | 6.38 | N/A | N/A | 0 |
| 2025-05-12 | FBRX | 6.35 | N/A | N/A | 0 |
| 2025-05-13 | FBRX | 6.8 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | FBRX | 5.59 | 76.3 | - | -3.60 |
| 2025-04-15 | FBRX | 5.84 | 76.3 | - | -3.60 |
| 2025-04-16 | FBRX | 7.01 | 76.3 | - | -3.60 |
| 2025-04-17 | FBRX | 7.34 | 76.3 | - | -3.60 |
| 2025-04-18 | FBRX | 7.34 | 76.3 | - | -3.60 |
| 2025-04-21 | FBRX | 7.12 | 76.3 | - | -3.60 |
| 2025-04-22 | FBRX | 6.85 | 76.3 | - | -3.60 |
| 2025-04-23 | FBRX | 6.05 | 76.3 | - | -3.60 |
| 2025-04-24 | FBRX | 6.99 | 76.3 | - | -3.60 |
| 2025-04-25 | FBRX | 6.71 | 76.3 | - | -3.60 |
| 2025-04-28 | FBRX | 7.12 | 76.3 | - | -3.60 |
| 2025-04-29 | FBRX | 7.34 | 76.3 | - | -3.60 |
| 2025-04-30 | FBRX | 7.30 | 76.3 | - | -3.60 |
| 2025-05-01 | FBRX | 7.16 | 76.3 | - | -3.60 |
| 2025-05-02 | FBRX | 6.96 | 76.3 | - | -3.60 |
| 2025-05-05 | FBRX | 6.66 | 76.3 | - | -3.60 |
| 2025-05-06 | FBRX | 6.38 | 76.3 | - | -3.60 |
| 2025-05-07 | FBRX | 6.19 | 76.3 | - | -3.60 |
| 2025-05-08 | FBRX | 6.60 | 76.3 | - | -3.60 |
| 2025-05-09 | FBRX | 6.38 | 76.3 | - | -3.60 |
| 2025-05-12 | FBRX | 6.28 | 76.3 | - | -3.60 |
| 2025-05-13 | FBRX | 6.80 | 76.3 | - | -3.60 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-15 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-16 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-17 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-18 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-21 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-22 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-23 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-24 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-25 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-28 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-04-29 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-04-30 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-01 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-02 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-05 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-06 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-07 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-08 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-09 | FBRX | 1.82 | 4.46 | 1.97 |
| 2025-05-12 | FBRX | 1.82 | 4.46 | 2.06 |
| 2025-05-13 | FBRX | 1.82 | 4.46 | 2.06 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-2.74
Avg. EPS Est. Next Quarter
-1.11
Insider Transactions
1.82
Institutional Transactions
4.46
Beta
2.77
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
8
Growth Score
21
Sentiment Score
8
Actual DrawDown %
99.5
Max Drawdown 5-Year %
Target Price
59
P/E
Forward P/E
PEG
P/S
P/B
0.83
P/Free Cash Flow
EPS
-16.47
Average EPS Est. Cur. Y
-3.6
EPS Next Y. (Est.)
-2.25
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.19
Return on Equity vs Sector %
-91.3
Return on Equity vs Industry %
-74.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.04
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 14
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading